MSC Industrial Direct
MSM
$122.92
+0.27%
MSC Industrial Direct Co., Inc. is a North American industrial distributor founded in 1941, selling metalworking cutting tools and a broad breadth of maintenance, repair, and operations (MRO) supplies to manufacturers, machine shops, and institutional customers, with over 95% of revenue generated in North America. The company is a scaled, high-touch distributor whose identity rests on deep metalworking specialization, a large catalog, and a field sales model that differentiates it from broadline MRO competitors and pure e-commerce players. The current investor debate centers on whether MSC can return to consistent volume growth after a multi-quarter stretch of soft industrial demand, with the most recent quarter showing a notable 7.8% year-over-year revenue acceleration and a sharp sequential margin recovery that has revived the recovery thesis. At the same time, a steep single-day price decline in late October and a consensus 'hold' rating underscore lingering skepticism about the durability of that rebound and the company's premium valuation relative to its historical band.…
MSM
MSC Industrial Direct
$122.92
Investment Opinion: Should I buy MSM Today?
Rating: Hold. The core thesis is that MSC is a quality industrial distributor undergoing a genuine but unproven margin recovery, and at $113.86 the stock offers a balanced risk/reward with 17.5% upside to the $133.75 average target but limited margin of safety given a 29.87x trailing PE. The consensus 'hold' rating (mean 2.55) and the wide $73–$155 target range reinforce that this is not a high-conviction buy at current levels.
Supporting evidence is mixed but leans constructive. Revenue grew 7.82% year over year in Q3 2026 to $1.047 billion, operating margin recovered to 10.19% from 7.33%, and free cash flow TTM of $219.9 million is solid. The forward PE of 17.53x implies a 41% earnings rebound, and the 2.92% dividend yield exceeds the sector average. However, the trailing PE of 29.87x, EV/EBITDA of 17.14x, and PEG of 2.54 are premium multiples for a 5.55% net margin business, and the 87.3% payout ratio limits flexibility.
The biggest risks are a failure of the margin recovery, a manufacturing demand downturn, and valuation compression. This Hold would upgrade to Buy if operating margin holds above 10% for two consecutive quarters and the stock pulls back toward $100 (forward PE ~13.7x), or downgrade to Sell if revenue growth decelerates below 3% or operating margin falls below 8%. Relative to its own history, the PS ratio of 1.66x is well below the 4.3x–6.0x range of 2022–2026, suggesting the stock is not expensive on sales, but the PE near the top of its band means it is fairly to slightly overvalued on earnings.
Sign up to view all
MSM 12-Month Price Forecast
MSC presents a balanced risk/reward at $113.86: the Q3 2026 revenue and margin recovery is real, but the stock's premium trailing multiple and recent 15.3% single-day collapse show the market is skeptical. The forward PE of 17.53x offers reasonable value if the $7.32 EPS consensus is achieved, but the 87.3% payout ratio and volatile free cash flow limit downside protection. I would upgrade to bullish if operating margin holds above 10% for two consecutive quarters and the stock stabilizes above $120, or downgrade to bearish if revenue growth falls below 3% or the stock breaks below the $112.43 post-selloff low.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on MSC Industrial Direct's 12-month outlook, with a consensus price target around $134.63 and implied upside of +9.5% versus the current price.
Average Target
$134.63
0 analysts
Implied Upside
+9.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$73 - $159
Analyst target range
Eight analysts cover MSC, and the consensus recommendation is 'hold' with a mean rating of 2.55 on a scale where 1 is strong buy and 5 is strong sell, indicating a neutral-to-cautious stance. The average target price is $133.75, which implies roughly 17.5% upside from the current $113.86, a meaningful gap that suggests analysts see the recent selloff as overdone even as they refrain from outright bullish calls. The consensus leans neutral rather than bearish, with the average target sitting almost exactly at the 52-week high of $133.95, implying the Street expects a full recovery to prior highs.
The target range is extremely wide, from a low of $73.00 to a high of $155.00, a spread of more than 112% of the current price that signals high uncertainty and divergent views on the recovery. The high target of $155 assumes multiple expansion and a full earnings recovery toward the $7.32 consensus EPS, while the low target of $73 prices in margin compression and a return to the demand trough. Institutional ratings show a mixed recent pattern: KeyBanc upgraded to Overweight from Sector Weight in April 2026 and reiterated in June and July, DA Davidson maintained Buy, but JPMorgan downgraded to Neutral from Overweight in February 2026 and Wolfe Research moved to Peer Perform from Outperform in October 2025, suggesting analysts are split on the durability of the rebound and the wide spread reflects genuine disagreement rather than strong conviction.
Bulls vs Bears: MSM Investment Factors
The bull case rests on a genuine fundamental inflection: 7.8% revenue growth and a sharp margin recovery in Q3 2026, supported by a low-leverage balance sheet and an analyst target implying 17.5% upside. The bear case centers on valuation and momentum: a 29.87x trailing PE for a 5.55% net margin business, a 15.3% single-day collapse that has not been recovered, and a 'hold' consensus with a 112% target spread. On balance, the bear evidence currently carries more weight because the stock's premium multiple leaves little room for error and the recent price action signals that the market is questioning the durability of the rebound. The single most important tension is whether the Q3 margin recovery is sustainable—if operating margins hold above 10%, the forward PE of 17.5x looks attractive; if they revert toward 7%, the stock is expensive.
Bullish
- Revenue re-acceleration to 7.8% YoY: Q3 2026 revenue of $1.047 billion grew 7.82% year over year, the strongest print in at least four quarters and a clear acceleration from the prior-year comparable of $971.1 million. The sequential jump from Q2's $917.8 million also suggests the demand trough may be behind the company.
- Sharp operating margin recovery: Operating margin expanded to 10.19% in Q3 2026 from 7.33% in Q2, driving operating income to $106.7 million from $67.2 million sequentially. Net margin more than doubled from 4.56% to 7.67%, demonstrating meaningful operating leverage on modest revenue growth.
- Analyst target implies 17.5% upside: The average analyst target price of $133.75 sits 17.5% above the current $113.86 and essentially at the 52-week high of $133.95. Even with a 'hold' consensus, the Street's mean target signals the recent selloff is viewed as overdone.
- Conservative balance sheet with low leverage: Debt-to-equity of 0.37, current ratio of 1.78, and interest coverage of 19.8x provide substantial financial flexibility. Free cash flow TTM of $219.9 million comfortably covers the dividend despite a high 87.3% payout ratio.
Bearish
- Premium valuation versus sector: Trailing PE of 29.87x, EV/EBITDA of 17.14x, and P/B of 4.67x are rich for a distributor with a 5.55% net margin and 7.99% operating margin. The PEG ratio of 2.54 indicates the market is paying more than 2.5x the growth rate.
- Momentum breakdown and relative weakness: The stock is down 8.25% over the past month and 9.38% over three months, underperforming the S&P 500 by 7.23 and 12.23 percentage points respectively. The 15.3% single-day drop on October 22 suggests a company-specific shock that has not been fully reversed.
- High dividend payout limits flexibility: The payout ratio of 87.3% consumes nearly all earnings, leaving little cushion for reinvestment or error. Quarterly free cash flow has been volatile, including just $7.4 million in Q1 2026 due to a $57.6 million working capital build.
- Split analyst sentiment and wide target range: The consensus rating is 'hold' with a mean of 2.55, and targets range from $73 to $155—a 112% spread. JPMorgan downgraded to Neutral in February 2026 and Wolfe moved to Peer Perform, reflecting genuine disagreement on the recovery's durability.
MSM Technical Analysis
MSC is in a sustained, choppy uptrend on a 1-year basis, with the stock up 26.89% versus a 13.13% gain for the S&P 500, a relative strength advantage of 13.76 percentage points. At a current price of $113.86 against a 52-week range of $78.80 to $133.95, the stock sits at roughly 63.5% of its 52-week range, meaning it has surrendered a meaningful portion of its highs but remains well above the lows. That positioning is neither a momentum breakout nor a falling knife; it reflects a stock that ran hard through the summer and is now digesting gains in a corrective phase. Year-to-date the stock is still up 32.64% versus 11.45% for the SPY, so the longer-term trend remains intact despite the recent damage.
Short-term momentum has deteriorated sharply and now diverges from the longer-term trend. The stock is down 8.25% over the past month and 9.38% over three months, versus a 1.02% decline and 2.85% gain for the SPY over the same windows, producing relative strength readings of -7.23 and -12.23 percentage points. The most striking data point is the single-session collapse from $132.82 on October 21 to $112.43 on October 22, a roughly 15.3% drawdown that aligns with the reported max drawdown of -15.35% and suggests a company-specific shock rather than broad market weakness. The modest 1.27% bounce to $113.86 on elevated volume of 2.32 million shares indicates tentative stabilization but not confirmed reversal, and the divergence between a positive 1-year trend and negative 1-month/3-month momentum is a classic warning of trend exhaustion or a repricing event.
Key technical levels are now clearly defined by the recent action. Resistance sits at the 52-week high of $133.95, with the October 21 close of $132.82 acting as an immediate ceiling; a reclaim of that zone would signal the selloff was an overreaction and re-open the highs. Support is anchored by the 52-week low of $78.80, with the post-selloff low near $112.43 as the first line of defense; a breakdown below that level would confirm a deeper trend reversal and likely target the mid-$100s or lower. Volatility is elevated, evidenced by the 15.35% max drawdown and the wide 52-week range spanning roughly 70% from low to high, and the short ratio of 3.47 days-to-cover indicates meaningful short interest that could amplify moves in either direction.
Beta
0.81
0.81x market volatility
Max Drawdown
-15.3%
Largest decline past year
52-Week Range
$79-$134
Price range past year
Annual Return
+46.0%
Cumulative gain past year
| Period | MSM Return | S&P 500 |
|---|---|---|
| 1m | -1.3% | +0.7% |
| 3m | -0.4% | +3.0% |
| 6m | +19.8% | +6.8% |
| 1y | +46.0% | +11.9% |
| ytd | +43.2% | +12.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MSM Fundamental Analysis
Revenue is re-accelerating after a soft patch. The most recent quarter (ended May 30, 2026) delivered revenue of $1.047 billion, up 7.82% year over year, a clear improvement from the prior-year comparable quarter's $971.1 million and from the sequential Q2 2026 figure of $917.8 million. The trailing four quarters show a rising trajectory: $978.2 million (Q4 2025), $965.7 million (Q1 2026), $917.8 million (Q2 2026), and $1.047 billion (Q3 2026), with the Q3 print the strongest of the group and the Q2 dip reflecting normal seasonality and soft demand. The segment data is reported as a single reportable segment at $1.047 billion, so growth is broad-based rather than driven by a specific business line, and the 7.8% growth rate is a meaningful acceleration that supports the recovery narrative if it persists.
Profitability is solid and margins are recovering sharply. Q3 2026 net income was $80.36 million on a 7.67% net margin, with gross margin of 41.11% and operating margin of 10.19%, a substantial improvement from Q2 2026's 4.56% net margin and 7.33% operating margin. Gross margin has been remarkably stable in the 40.4% to 41.1% band over the past several quarters, but operating leverage is evident: operating income rose to $106.7 million in Q3 from $67.2 million in Q2 and $81.1 million in Q1, even as revenue grew only modestly sequentially. The company is clearly profitable, with trailing EPS of $1.44 in the latest quarter and a TTM net margin of 5.55%, and the margin expansion reflects cost discipline and volume leverage rather than one-time items.
Financial health is sound but cash generation is lumpy. Debt-to-equity is a conservative 0.37, the current ratio is 1.78, and interest coverage is a comfortable 19.8x, indicating low leverage risk. Free cash flow TTM is $219.9 million, but quarterly FCF has been volatile ($80.9 million in Q3 2026, $73.1 million in Q2, just $7.4 million in Q1 due to a $57.6 million working capital build), and the dividend consumes a high 87.3% of earnings with a payout ratio of 0.87, leaving limited cushion. ROE of 15.6% and ROA of 9.4% are respectable for a distributor, but the high payout and working-capital swings mean the company has less internal funding flexibility than the balance sheet alone suggests.
Quarterly Revenue
$1.0B
2026-05
Revenue YoY Growth
+7.8%
YoY Comparison
Gross Margin
41.1%
Latest Quarter
Free Cash Flow
$219930000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MSM Overvalued?
Because MSC is profitable (net income of $80.36 million in the latest quarter and positive TTM earnings), the PE ratio is the appropriate primary metric. The trailing PE is 29.87x versus a forward PE of 17.53x, an unusually wide gap that implies the market expects a substantial earnings rebound; the forward multiple is based on consensus EPS of $7.32 versus a trailing EPS that appears depressed by the recent margin trough. That 41% compression from trailing to forward PE signals the market is pricing in a recovery year, and the stock's valuation is highly sensitive to whether that recovery materializes.
Against the broader industrial distribution sector, MSC trades at a premium on most measures. Its PS ratio of 1.66x and EV/Sales of 1.68x are moderate, but the trailing PE of 29.87x, EV/EBITDA of 17.14x, and P/B of 4.67x are rich for a distributor with a 5.55% net margin and 7.99% operating margin. The PEG ratio of 2.54 suggests the market is paying more than 2.5x the growth rate, and the dividend yield of 2.92% is above the sector average but supported by a stretched 87.3% payout ratio. The premium is partially justified by MSC's specialized metalworking niche and 15.6% ROE, but the margin profile is below what a 30x trailing multiple typically demands.
Historically, MSC's PE has ranged widely, from roughly 10.6x in Q4 2022 to 30.9x in Q2 2026, with the current 29.87x sitting near the top of that band. The PS ratio of 1.66x, however, is well below the 4.3x to 6.0x range seen through 2022-2026, reflecting the market cap of $6.65 billion against roughly $4 billion in revenue and suggesting the stock is cheaper on sales than it has been historically. The divergence between a historically high PE and a historically low PS implies the market is pricing depressed earnings rather than an expensive business, and a normalization of margins toward prior peaks would compress the PE meaningfully without requiring multiple expansion.
PE
29.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 11x~31x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate but real. The dividend consumes 87.3% of earnings, leaving minimal retained cash, and quarterly free cash flow has swung from $80.9 million in Q3 2026 to just $7.4 million in Q1 2026 due to a $57.6 million working capital build. Revenue is concentrated in North America (>95%) and in metalworking/MRO distribution, so a downturn in U.S. manufacturing activity would hit the top line directly. Earnings are also volatile: net margin ranged from 4.56% in Q2 2026 to 7.67% in Q3 2026, a swing that shows how quickly profitability can compress.
Market and competitive risks center on valuation compression. At 29.87x trailing earnings and 17.14x EV/EBITDA, MSC trades at a premium to broadline distributors, and its PEG of 2.54 offers little margin of safety. The stock's beta is not provided, but its 15.35% max drawdown and 70% 52-week range indicate above-market volatility; the 3.47-day short ratio adds potential for amplified moves. Competitive threats from e-commerce and broadline MRO players could pressure pricing, while a manufacturing recession would delay the recovery the forward multiple assumes. Recent news is absent, but the October 22 selloff itself is a warning that sentiment can shift abruptly.
In a worst-case scenario, U.S. manufacturing demand rolls over, Q3's margin recovery proves temporary, and consensus EPS of $7.32 is cut toward the low estimate of $6.98 or below. The stock could retest its 52-week low of $78.80, which would represent a 30.8% loss from the current $113.86, or fall to the analyst low target of $73.00, a 35.9% decline. A break below the post-selloff low of $112.43 would likely accelerate selling toward the mid-$100s first, with the $78.80 level as the ultimate downside anchor.
FAQ
The most severe risk is valuation compression: a 29.87x trailing PE could de-rate toward 20x if the margin recovery stalls, implying a 33% downside. Second is cyclical demand risk—over 95% of revenue is North American, so a manufacturing downturn would hit revenue and earnings directly. Third is dividend sustainability, with an 87.3% payout ratio and volatile free cash flow (as low as $7.4 million in Q1 2026). Fourth is competitive pressure from e-commerce and broadline MRO distributors, which could erode MSC's metalworking niche and pricing power.
The 12-month forecast has three scenarios: a 25% probability bull case targeting $140–$155 (full manufacturing recovery, margin above 10.5%), a 50% probability base case targeting $125–$140 (revenue growth 5–7%, margin around 10%), and a 25% probability bear case targeting $73–$85 (manufacturing downturn, margin back to 7%). The base case is most likely, anchored by the $133.75 analyst average target and the $7.32 consensus EPS. The key assumption is that U.S. manufacturing activity stabilizes without a recession and gross margin holds above 40.5%.
MSM is fairly to slightly overvalued on earnings but cheap on sales. The trailing PE of 29.87x sits near the top of its historical 10.6x–30.9x band, while the PS ratio of 1.66x is well below the 4.3x–6.0x range seen in 2022–2026. The market is pricing a recovery: the forward PE of 17.53x implies a 41% earnings rebound to $7.32 per share. If that recovery materializes, the stock is reasonably valued; if not, the trailing multiple is expensive for a 5.55% net margin distributor. The EV/EBITDA of 17.14x and P/B of 4.67x confirm a premium to sector averages.
MSM is a reasonable buy only for patient, income-oriented investors at current levels. The stock trades at $113.86, 17.5% below the average analyst target of $133.75, and the forward PE of 17.53x is attractive if the $7.32 EPS consensus is met. However, the trailing PE of 29.87x and PEG of 2.54 leave little margin of safety, and the 15.3% single-day drop on October 22 shows sentiment is fragile. The biggest downside risk is a retest of the $78.80 52-week low, a 30.8% decline. A better entry point would be near $100, where the forward PE would be about 13.7x.
MSM is better suited for medium- to long-term investment than short-term trading. The stock's 15.35% max drawdown, 70% 52-week range, and 3.47-day short ratio indicate elevated volatility that makes short-term timing difficult. The 2.92% dividend yield and 87.3% payout ratio appeal to income investors, but the cyclical earnings profile means a minimum holding period of 2–3 years is needed to ride out a manufacturing cycle. Short-term traders could target the $112.43–$133.95 range, but the risk/reward is less favorable than for long-term holders collecting dividends while awaiting a full recovery.